SV

Suri Venkatachalam

Active Director Managing Director DIN 01095804
DIN 01095804 First appointment Jul 2003 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 3 historical roles
Total affiliations 7 Since Jul 2003
Shareholding value •••• Premium profile

About Suri Venkatachalam

Data last updated:

Suri Venkatachalam has 23 years in corporate governance. Holds Managing Director and Director roles. Currently with 4 companies, including Connexios Life Sciences Private Limited and Abexome Biosciences Private Limited. Formerly with 3 companies, such as Inexios Pharmaceuticals Private Limited and Consilience Research Advisors Llp. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹23.44 Cr; the largest is Foundation For Neglected Disease Research at ₹13.31 Cr (FY 2024).

DIN 01095804
Primary Designation Managing Director
First Appointment 25 Jul 2003
Oldest Company Age 23 yrs
Largest company Foundation For Neglected Disease Research · ₹13.31 Cr (FY 2024)
Combined revenue ₹23.44 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Jun 20172014₹13.31 Cr (FY 2024)Active
Achira Labs Private Limited U73100KA2009PTC051466
Director12 Nov 20092009₹8.98 Cr (FY 2026)Active
Blackbaza Coffee Private Limited U52100KA2016PTC086744
Director30 Sep 20242016₹1.15 Cr (FY 2025)Active
Abexome Biosciences Private Limited U73100KA2007PTC041611
Director01 Feb 20072007–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director15 Oct 20082006₹13.7 Lakh (FY 2025)Active
Designated Partner21 Apr 20162016–Active
Managing Director25 Jul 20032003₹7.17 Cr (FY 2016)Under Liquidation

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Connexios Life Sciences Private Limited
Abexome Biosciences Private Limited
Achira Labs Private Limited
Foundation For Neglected Disease Research
Premium access

Shareholding and investment profile for Suri Venkatachalam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suri Venkatachalam

Suri Venkatachalam has 23 years in corporate governance. Holds Managing Director and Director roles. Currently with 4 companies, including Connexios Life Sciences Private Limited and Abexome Biosciences Private Limited. Formerly with 3 companies, such as Inexios Pharmaceuticals Private Limited and Consilience Research Advisors Llp. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹23.44 Cr; the largest is Foundation For Neglected Disease Research at ₹13.31 Cr (FY 2024).

Suri Venkatachalam is associated with 4 companies as Managing Director and Director, including Foundation For Neglected Disease Research (₹13.31 Cr), Achira Labs Private Limited (₹8.98 Cr), Blackbaza Coffee Private Limited (₹1.15 Cr).

Suri Venkatachalam has expertise in General Business.

Suri Venkatachalam has 23 years in corporate governance.

By reported revenue, the largest current company of Suri Venkatachalam is Foundation For Neglected Disease Research, with revenue of ₹13.31 Cr (FY 2024).

The 3 current companies of Suri Venkatachalam that report revenue have a combined latest revenue of ₹23.44 Cr.

Suri Venkatachalam currently holds positions at 4 companies: Foundation For Neglected Disease Research (₹13.31 Cr), Achira Labs Private Limited (₹8.98 Cr), Blackbaza Coffee Private Limited (₹1.15 Cr), Abexome Biosciences Private Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available